Literature DB >> 17066056

Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity.

Robin A Felder1, Pedro A Jose.   

Abstract

Hypertension and salt sensitivity of blood pressure are two conditions the etiologies of which are still elusive because of the complex influences of genes, environment, and behavior. Recent understanding of the molecular mechanisms that govern sodium homeostasis is shedding new light on how genes, their protein products, and interacting metabolic pathways contribute to disease. Sodium transport is increased in the proximal tubule and thick ascending limb of Henle of the kidney in human essential hypertension. This Review focuses on the counter-regulation between the dopaminergic and renin-angiotensin systems in the renal proximal tubule, which is the site of about 70% of total renal sodium reabsorption. The inhibitory effect of dopamine is most evident under conditions of moderate sodium excess, whereas the stimulatory effect of angiotensin II is most evident under conditions of sodium deficit. Dopamine and angiotensin II exert their actions via G protein-coupled receptors, which are in turn regulated by G protein-coupled receptor kinases (GRKs). Polymorphisms that lead to aberrant action of GRKs cause a number of conditions, including hypertension and salt sensitivity. Polymorphisms in one particular member of this family-GRK4-have been shown to cause hyperphosphorylation, desensitization and internalization of a member of the dopamine receptor family, the dopamine 1 receptor, while increasing the expression of a key receptor of the renin-angiotensin system, the angiotensin II type 1 receptor. Novel diagnostic and therapeutic approaches for identifying at-risk subjects, followed by selective treatment of hypertension and salt sensitivity, might center on restoring normal receptor function through blocking the effects of GRK4 polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17066056     DOI: 10.1038/ncpneph0301

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  46 in total

Review 1.  Dopamine, the kidney, and hypertension.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

2.  Renal-Specific Silencing of TNF (Tumor Necrosis Factor) Unmasks Salt-Dependent Increases in Blood Pressure via an NKCC2A (Na+-K+-2Cl- Cotransporter Isoform A)-Dependent Mechanism.

Authors:  Shoujin Hao; Mary Hao; Nicholas R Ferreri
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

3.  Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.

Authors:  John J Gildea; Brandon A Kemp; Nancy L Howell; Robert E Van Sciver; Robert M Carey; Robin A Felder
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

4.  Sensing salt intake.

Authors:  Ines Armando; Pedro A Jose
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

Review 5.  Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.

Authors:  John J Gildea
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

Review 6.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

7.  Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.

Authors:  Junichi Yatabe; Hironobu Sanada; Sanae Midorikawa; Shigeatsu Hashimoto; Tsuyoshi Watanabe; Peter M Andrews; Ines Armando; Xiaoyan Wang; Robin A Felder; Pedro A Jose
Journal:  Hypertens Res       Date:  2008-07       Impact factor: 3.872

Review 8.  Stress-induced sodium retention and hypertension: a review and hypothesis.

Authors:  Gregory A Harshfield; Yanbin Dong; Gaston K Kapuku; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

9.  Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.

Authors:  Bing Yao; Raymond C Harris; Ming-Zhi Zhang
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

10.  D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.

Authors:  Quansheng Lu; Yu Yang; Van Anthony Villar; Laureano Asico; John E Jones; Peiying Yu; Hewang Li; Edward J Weinman; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertens Res       Date:  2013-02-21       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.